The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension
- PMID: 30698486
- PMCID: PMC6540493
- DOI: 10.1177/2045894019831222
The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension
Abstract
Patients with isolated right ventricular (RV) failure have poor outcomes and minimal treatment options. We report a case where a durable RV assist device (RVAD) was implanted for end-stage RV failure from combined pre- and postcapillary pulmonary hypertension (PH) due in part to chronic thromboembolic PH using a temporary percutaneous RVAD as a bridging strategy. While the patient ultimately died from non-cardiovascular causes, there was significant improvement in markers of cardiogenic shock and hemodynamic RV function parameters without adverse effects from increased pulmonary artery pressures. More research is needed to identify an appropriate long-term mechanical support strategy for this patient population.
Keywords: CTEPH; PH; Protek Duo; RV failure; RVAD; mechanical circulatory support.
Figures
References
-
- Shehab S, Macdonald PS, Keogh AM, et al. Long-term biventricular HeartWare ventricular assist device support–Case series of right atrial and right ventricular implantation outcomes. J Heart Lung Transplant 2016; 35: 466–473. - PubMed
-
- Bernhardt AM, De By TM, Reichenspurner H, et al. Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support. Eur J Cardiothor Surg 2015; 48: 158–162. - PubMed
-
- Rosenzweig EB, Chicotka S, Bacchetta M. Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: Lessons learned. J Heart Lung Transplant 2016; 35: 1272–1274. - PubMed
LinkOut - more resources
Full Text Sources
